CLINT1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	22 studies	21% ± 5%	Explore
endothelial cell	21 studies	25% ± 9%	Explore
ciliated cell	19 studies	35% ± 17%	Explore
epithelial cell	17 studies	37% ± 20%	Explore
B cell	16 studies	22% ± 5%	Explore
regulatory T cell	16 studies	19% ± 3%	Explore
classical monocyte	15 studies	23% ± 10%	Explore
fibroblast	15 studies	22% ± 4%	Explore
basal cell	13 studies	35% ± 19%	Explore
plasma cell	12 studies	31% ± 13%	Explore
type II pneumocyte	11 studies	31% ± 12%	Explore
secretory cell	11 studies	36% ± 21%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	22% ± 4%	Explore
mucosal invariant T cell	11 studies	22% ± 5%	Explore
plasmacytoid dendritic cell	11 studies	32% ± 6%	Explore
macrophage	10 studies	23% ± 5%	Explore
mast cell	10 studies	27% ± 11%	Explore
club cell	10 studies	38% ± 17%	Explore
naive B cell	10 studies	21% ± 4%	Explore
non-classical monocyte	10 studies	24% ± 10%	Explore
CD16-positive, CD56-dim natural killer cell, human	10 studies	21% ± 4%	Explore
dendritic cell	10 studies	28% ± 14%	Explore
memory B cell	10 studies	18% ± 2%	Explore
T cell	9 studies	23% ± 5%	Explore
monocyte	9 studies	22% ± 4%	Explore
plasmablast	9 studies	46% ± 21%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	19% ± 4%	Explore
CD4-positive, alpha-beta T cell	9 studies	21% ± 5%	Explore
gamma-delta T cell	9 studies	23% ± 11%	Explore
respiratory goblet cell	8 studies	54% ± 9%	Explore
CD8-positive, alpha-beta T cell	8 studies	21% ± 5%	Explore
conventional dendritic cell	8 studies	28% ± 17%	Explore
myeloid cell	8 studies	23% ± 7%	Explore
adipocyte	8 studies	25% ± 6%	Explore
smooth muscle cell	8 studies	18% ± 1%	Explore
type I pneumocyte	7 studies	27% ± 7%	Explore
CD8-positive, alpha-beta memory T cell	7 studies	22% ± 4%	Explore
mature NK T cell	7 studies	20% ± 3%	Explore
hematopoietic stem cell	7 studies	24% ± 7%	Explore
endothelial cell of lymphatic vessel	6 studies	19% ± 2%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	6 studies	20% ± 3%	Explore
kidney loop of Henle epithelial cell	6 studies	26% ± 8%	Explore
abnormal cell	6 studies	27% ± 9%	Explore
microglial cell	6 studies	24% ± 6%	Explore
lymphocyte	6 studies	22% ± 6%	Explore
goblet cell	6 studies	31% ± 20%	Explore
hematopoietic precursor cell	5 studies	38% ± 17%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	5 studies	20% ± 4%	Explore
myofibroblast cell	5 studies	20% ± 4%	Explore
pericyte	5 studies	19% ± 3%	Explore
astrocyte	5 studies	27% ± 7%	Explore
oligodendrocyte precursor cell	5 studies	26% ± 10%	Explore
oligodendrocyte	5 studies	21% ± 4%	Explore
deuterosomal cell	4 studies	32% ± 14%	Explore
duct epithelial cell	4 studies	45% ± 15%	Explore
ionocyte	4 studies	28% ± 8%	Explore
squamous epithelial cell	4 studies	45% ± 18%	Explore
leukocyte	4 studies	20% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	21% ± 4%	Explore
precursor B cell	4 studies	24% ± 6%	Explore
T follicular helper cell	4 studies	20% ± 3%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	21% ± 5%	Explore
innate lymphoid cell	4 studies	22% ± 5%	Explore
vein endothelial cell	4 studies	19% ± 1%	Explore
hepatocyte	4 studies	46% ± 15%	Explore
GABAergic neuron	4 studies	37% ± 13%	Explore
glutamatergic neuron	4 studies	48% ± 16%	Explore
transit amplifying cell	4 studies	32% ± 20%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	30% ± 9%	Explore
IgA plasma cell	4 studies	25% ± 7%	Explore
effector CD8-positive, alpha-beta T cell	3 studies	18% ± 1%	Explore
renal alpha-intercalated cell	3 studies	21% ± 5%	Explore
common myeloid progenitor	3 studies	29% ± 13%	Explore
pro-B cell	3 studies	23% ± 2%	Explore
progenitor cell	3 studies	23% ± 1%	Explore
erythroblast	3 studies	21% ± 7%	Explore
endothelial cell of artery	3 studies	18% ± 2%	Explore
pancreatic ductal cell	3 studies	54% ± 27%	Explore
connective tissue cell	3 studies	22% ± 9%	Explore
enteroendocrine cell	3 studies	23% ± 4%	Explore
group 3 innate lymphoid cell	3 studies	25% ± 9%	Explore
interneuron	3 studies	36% ± 19%	Explore
neuron	3 studies	27% ± 6%	Explore
mucus secreting cell	3 studies	37% ± 14%	Explore
renal principal cell	3 studies	28% ± 11%	Explore
IgG plasma cell	3 studies	24% ± 6%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	13 studies	30% ± 18%	Explore
peripheral blood	11 studies	23% ± 8%	Explore
brain	7 studies	31% ± 12%	Explore
liver	5 studies	26% ± 10%	Explore
bone marrow	4 studies	24% ± 9%	Explore
kidney	4 studies	20% ± 4%	Explore
intestine	4 studies	21% ± 4%	Explore
adipose	4 studies	23% ± 3%	Explore
uterus	3 studies	30% ± 18%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	6574.79	1445 / 1445	100%	70.57	183 / 183
ovary	100%	3645.44	180 / 180	100%	54.26	430 / 430
lung	100%	5281.88	577 / 578	100%	63.76	1155 / 1155
intestine	100%	6046.87	966 / 966	100%	62.80	526 / 527
stomach	100%	4753.32	359 / 359	100%	64.85	285 / 286
breast	100%	4900.60	459 / 459	99%	52.79	1112 / 1118
bladder	100%	5418.71	21 / 21	99%	49.37	499 / 504
uterus	100%	3880.35	170 / 170	99%	60.64	454 / 459
pancreas	100%	3703.44	328 / 328	99%	77.71	176 / 178
prostate	100%	3855.36	245 / 245	99%	49.07	495 / 502
thymus	100%	5871.01	653 / 653	98%	51.30	595 / 605
kidney	100%	5349.37	89 / 89	98%	54.72	885 / 901
liver	100%	4775.95	226 / 226	97%	41.17	394 / 406
adrenal gland	100%	4534.34	258 / 258	96%	35.53	221 / 230
skin	100%	6945.85	1809 / 1809	96%	42.15	451 / 472
brain	95%	1865.93	2523 / 2642	99%	33.80	700 / 705
adipose	100%	5039.84	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	53.76	29 / 29
muscle	100%	4594.70	803 / 803	0%	0	0 / 0
spleen	100%	4237.37	241 / 241	0%	0	0 / 0
ureter	0%	0	0 / 0	100%	9.69	1 / 1
blood vessel	100%	3879.87	1334 / 1335	0%	0	0 / 0
tonsil	0%	0	0 / 0	98%	76.24	44 / 45
heart	94%	2732.33	808 / 861	0%	0	0 / 0
peripheral blood	85%	2507.08	789 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	83%	20.29	66 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0048268	Biological process	clathrin coat assembly
GO_0006897	Biological process	endocytosis
GO_0043231	Cellular component	intracellular membrane-bounded organelle
GO_0030125	Cellular component	clathrin vesicle coat
GO_0005768	Cellular component	endosome
GO_0005654	Cellular component	nucleoplasm
GO_0005829	Cellular component	cytosol
GO_0005794	Cellular component	Golgi apparatus
GO_0016020	Cellular component	membrane
GO_0005886	Cellular component	plasma membrane
GO_0048471	Cellular component	perinuclear region of cytoplasm
GO_0030276	Molecular function	clathrin binding
GO_0045296	Molecular function	cadherin binding
GO_0005515	Molecular function	protein binding
GO_0005543	Molecular function	phospholipid binding

IV. Literature review

[source]

Gene name	CLINT1
Protein name	Clathrin interactor 1 Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR) Clathrin interactor 1 isoform 1 Alternative protein CLINT1 Clathrin interactor 1 isoform 2
Synonyms	KIAA0171 ENTH EPN4 EPNR
Description	FUNCTION: Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). May have a role in transport via clathrin-coated vesicles from the trans-Golgi network to endosomes. Stimulates clathrin assembly. .
Accessions	ENST00000521615.1 ENST00000523908.5 [Q14677-3] ENST00000521047.1 ENST00000522381.1 Q14677 A0A0S2Z4Y4 H0YD52 L8EAP9 ENST00000523094.5 [Q14677-2] ENST00000530742.5 [Q14677-2] H0YDU9 A0A0S2Z5H3 H0YCL3 ENST00000411809.7 [Q14677-1]

CLINT1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review